[37th SRE][Issue] No Major M&A Deals for the Second Consecutive Year… Expectations and Concerns Are “Half and Half”
[37th SRE]
Samba’s Acquisition of ‘Polypeptide’ Ranks No. 1 Among Most Anticipated Investments
E-Mart and Shinsegae’s Acquisition of SSG.com Shares Tops List of Concerns
Doosan, Hana Investment & Securities, and Lotte Ranked Simultaneously for ‘Expectations and Concerns’
[Edaily Marketin Hur Jieun Reporter] Amid a slump that has persisted since last year, this year’s mergers and acquisitions (M&A) market saw only a few “big deals” worth trillions of won come to fruition. Market attention focused on “long-standing” financial deals involving firms such as Acuon Capital and KDB Life Insurance, as well as major transactions led by large conglomerates, including Samsung Biologics’ acquisition of Switzerland’s Polypeptide Group and Doosan Group’s acquisition of SK Siltron. Credit market experts expressed both optimism and concern regarding these deals, while E-Mart and Shinsegae—which were left holding the stakes of financial investors (FIs) following failed initial public offerings (IPOs)—were branded as the most concerning investments.
In the 37th SRE survey, 58 out of 197 bond market experts (29.4%) cited Samsung Biologics’ acquisition of the Swiss Polypeptide Group as the M&A and investment deal with the highest expected returns. Hanwha Life’s acquisition of Acuon Capital and Acuon Savings Bank followed with 49 votes (24.9%), followed by the Doosan Group’s acquisition of SK Siltron (35 votes, 17.8%), Korea Investment & Finance Holdings’ acquisition of KDB Life Insurance (26 votes, 13.2%), and the Lotte Group’s sale of Lotte Rental (10 votes, 5.1%). Conversely, the most concerning investment was the acquisition of a financial investor (FI) stake in SSG.com by E-Mart and Shinsegae, which received 57 votes (28.9%). In effect, the vote counts for the top “most anticipated” investment (58 votes) and the top “most concerning” investment (57 votes) were virtually the same. An SRE advisory committee member noted, “The M&A market itself isn’t that large these days,” adding, “The atmosphere of market contraction is clearly reflected in the voting results.”
Samsung Biologics signed an agreement last July to acquire Polypeptide Group for approximately 2.7 trillion won (1.46 billion Swiss francs). This is the largest M&A deal in the domestic pharmaceutical and biotech industry. The company will secure key client relationships—including with Eli Lilly—and expand its pipeline. In the tender offer that closed on November 2, 97.98% of the target shares were tendered, exceeding all acquisition thresholds. The company plans to proceed with a mandatory tender offer to make Polypeptide a wholly-owned subsidiary. By job category, 21 credit analysts (CAs) and 37 non-CAs expressed optimism. Since the acquisition will be funded by cash on hand and external borrowing, the actual amount borrowed and interest expenses are seen as key variables that will determine the financial burden following the acquisition.
Hanwha Life’s acquisition of Acuon, which ranked second, received 49 votes. On September 30, Hanwha Life’s board of directors resolved to acquire Acuon Capital’s common stock for 440 billion won, securing a 50.54% stake. Considering the impact on capital adequacy, the company opted for a joint acquisition with private equity fund (PEF) manager Centroid and aims to close the deal by the end of the year. Once Acuon Savings Bank—with total assets of 5.1 trillion won—is incorporated, it will combine with the existing Hanwha Savings Bank to create a savings bank business base worth approximately 6.5 trillion won. Korea Ratings placed Acuon Capital’s rating (A) under review for an upgrade, noting that if Hanwha Life becomes the major shareholder, the possibility of support from the affiliate group could be reflected. Twenty-eight bond managers (MG) expressed optimism about this deal, which is interpreted as reflecting expectations of improved creditworthiness and more stable funding conditions following the integration into the affiliate group.
Doosan Group’s acquisition of SK Siltron ranked third in terms of expectations (35 votes) and second in terms of concerns (32 votes, 16.2%) simultaneously. On July 31, Doosan signed an agreement to acquire a 70.61% stake in SK Siltron for 2.3 trillion won. The acquisition price will be financed with 1.3 trillion won in internal funds and 1 trillion won in borrowings, with the final payment and transaction closing scheduled for January 2027. While the portfolio—which now includes semiconductor materials, back-end processes, and wafers—is a positive factor, a financial burden is expected to be inevitable. According to Korea Ratings, which based its estimates on 1 trillion won in acquisition financing, Doosan’s consolidated debt-to-equity ratio will rise from 161.1% as of the end of March to 191.0%. While Korea Ratings maintained its “positive” outlook for Doosan (BBB+), it kept SK Siltron (A+) under review for a downgrade, citing the possibility that support from the SK Group could weaken. The fact that the silicon carbide (SiC) division alone posted an operating loss of 214.4 billion won last year could also act as a burden.
Opinions were also evenly split between optimism (26 votes, 13.2%) and concern (27 votes, 13.7%) regarding Korea Investment & Finance Group’s acquisition of KDB Life Insurance. Although the Korea Development Bank (KDB) selected Korea Investment & Finance Group as the preferred bidder last August—after its seventh attempt to sell the company since 2014—the share purchase agreement (SPA) has yet to be signed even two months later. While details such as the purchase price and capital injection are being negotiated, the 1 trillion won capital increase demanded by KDB remains a key sticking point. Given the precedent where Hana Financial Group withdrew from the acquisition despite being selected as the preferred bidder due to financial burdens, whether the deal will close remains a key variable.
Concerns about Lotte Group’s sale of Lotte Rental outweighed expectations. While only 10 votes expressed optimism, 25 votes (12.7%) expressed concern—2.5 times as many—and 17 of the 19 non-CA respondents who selected “concern” were bond managers. Last August, Lotte signed an agreement to sell the entire 61.2% stake in Lotte Rental held by Hotel Lotte and Busan Lotte Hotel to TPG for a total of 1.3105 trillion won. This deal was finalized after the Affinity acquisition fell through in January of this year due to the Fair Trade Commission’s rejection of the merger; it cleared the FTC’s approval hurdle and was completed on October 30. Although TPG is financing the acquisition without external borrowing, NICE Credit Rating noted that, given the nature of private equity funds (PEFs), financial policies—such as increased dividends—may change during the capital recovery process; therefore, the company’s business strategy and financial stability trends must be monitored following the acquisition.
The acquisition of the FI stake in SSG.com by E-Mart and Shinsegae was cited as the most concerning investment. In particular, with 25 respondents (43.9%) citing it, it accounted for the highest proportion among the top five concerns. In November 2024, the new FI, Olympus First, acquired a 30% stake from the existing FIs(Affinity and BRV Capital), temporarily alleviating pressure to recoup investment funds. However, with an IPO now looking unlikely, E-Mart and Shinsegae exercised their call options in June of this year and acquired the 30% stake on August 26 for a total of 1.2711 trillion won. E-Mart contributed 827.5 billion won, while Shinsegae contributed 443.6 billion won. E-Mart invested an additional 1.3596 trillion won this month in the Paramount Skydance–Warner Bros. Discovery merger, bringing the total funds injected over the past two months to nearly 2.2 trillion won. NICE Credit Rating estimated that, assuming the investment funds are financed entirely through borrowing, E-Mart’s debt-to-equity ratio would rise from 34.6% to 39.0%. However, this remains well below the 50% threshold for a rating downgrade review. An SRE advisory committee member stated, “Shinsegae has had many failed M&A deals, starting with 11st. Isn’t Starbucks the only one that went well?” They added, “This is likely why it ranks among the top concerns in the negative assessment.”
The fifth-ranked concern was DB Insurance’s acquisition of U.S.-based Potegra (19 votes, 9.6%). DB Insurance signed an agreement last September to acquire 100% of Potegra’s shares for $1.65 billion (approximately 2.3 trillion won) and completed the acquisition this past May. However, its consolidated solvency ratio (K-ICS) fell from 232.1% at the end of the first quarter to an estimated 204.3% at the end of the second quarter, bringing it close to the lower end of the management target range (200–220%). Concerns were greater among non-CA respondents (16) than among CA respondents (3).
These results clearly demonstrate that, particularly for deals in the trillions of won range, post-acquisition financing and financial burdens are key factors in determining the credit market’s assessment. According to Hana Securities, the total value of domestic M&A transactions completed in the first three quarters of this year was 11.2984 trillion won, less than half of the figure for the same period last year (30.2761 trillion won). All eyes are on whether the large deals set to close by the end of the year will serve as a catalyst for a market rebound.
[This article is excerpted from the 37th edition of the SRE (Survey of Credit Ratings by Edaily) booklet produced by Edaily.]
As interest rate hikes increase the burden of corporate financing, attention is focusing on the possibility of credit rating upgrades for BBB-rated companies. With BBB-rated companies such as Hanjin a…
HITEJINRO has promoted seven executives in its first year-end regular executive reshuffle since CEO Jang In-seop took office. HITEJINRO, which replaced its CEO last year for the first time in 14 years…
Anthropic logo. (Photo courtesy of Anthropic)
Anthropic, the developer of the artificial intelligence (AI) model “Claude,” has listed on the U.S. Nasdaq amid significant market interest, securing …